PTEN and cancer: Decreased expression of PTEN resulted in the stabilization of the chromatin helicase DNA-binding factor CHD1, which engages the trimethyl lysine-4 histone H3 modification to activate the transcription of cancer-promoting genes involved in the NF-κB pathway [127].